Elizabeth Iorns
- Molecular Biology top 5%
- Oncology top 5%
- Cancer Research top 5%
- Pulmonary and Respiratory Medicine top 10%
- Genetics top 10%
- Co-authors
- Nicholas C. TurnerChristopher J. LordAlan AshworthAndrew TuttTimothy M. ErringtonBrian A. NosekJorge S. Reis‐FilhoRichard Elliott
- Topics
- RNA modifications and cancer (7 papers)Cancer Cells and Metastasis (6 papers)Cancer-related molecular mechanisms research (6 papers)
- Partner nations
- United StatesUnited KingdomNetherlands
In The Last Decade
Elizabeth Iorns
49 papers receiving 2.2k citations
Hit Papers
Peers
Comparison fields: 5 of 150
- Molecular Biology 1.5k
- Oncology 796
- Cancer Research 522
- Pulmonary and Respiratory Medicine 280
- Genetics 228
Countries citing papers authored by Elizabeth Iorns
This map shows the geographic impact of Elizabeth Iorns's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth Iorns with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth Iorns more than expected).
Fields of papers citing papers by Elizabeth Iorns
This network shows the impact of papers produced by Elizabeth Iorns. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth Iorns. The network helps show where Elizabeth Iorns may publish in the future.
Co-authorship network of co-authors of Elizabeth Iorns
This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth Iorns. A scholar is included among the top collaborators of Elizabeth Iorns based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth Iorns. Elizabeth Iorns is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 46 | |
| 2 | 11 | |
| 3 | 18 | |
| 4 | 2 | |
| 5 | 1 | |
| 6 | 1 | |
| 7 | 1 | |
| 8 | 1 | |
| 9 | 1 | |
| 10 | 1 | |
| 11 | 1 | |
| 12 | 34 | |
| 13 | 126 | |
| 14 | 48 | |
| 15 | 18 | |
| 16 | FGFR1 Amplification Drives Endocrine Therapy Resistance and Is a Therapeutic Target in Breast Cancerbreakdown → | 544 |
| 17 | 57 | |
| 18 | 108 | |
| 19 | 3 | |
| 20 | 204 |
About Elizabeth Iorns
Elizabeth Iorns is a scholar working on Cancer Research, Statistics, Probability and Uncertainty and Oncology, having authored 52 papers that have together received 2.3k indexed citations. Recurring topics across this work include RNA modifications and cancer (7 papers), Cancer Cells and Metastasis (6 papers) and Cancer-related molecular mechanisms research (6 papers). The work is most often cited by research in Cancer Research (522 citations), Oncology (796 citations) and Molecular Biology (1.5k citations). Elizabeth Iorns has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include Nicholas C. Turner, Christopher J. Lord, Alan Ashworth, Andrew Tutt, Timothy M. Errington, Brian A. Nosek, Jorge S. Reis‐Filho, Richard Elliott, Nicole Perfito and Anita Grigoriadis. Their work appears in journals such as The EMBO Journal, PLoS ONE and Nature Reviews Drug Discovery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.